Skip to main content

GBP3 KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 3 and 1 bp insertion in exon 3.

Be the first to review this product! Submit a review

Images

Sanger Sequencing - Human GBP3 knockout A549 cell line (AB267190), expandable thumbnail
  • Sanger Sequencing - Human GBP3 knockout A549 cell line (AB267190), expandable thumbnail

Key facts

Cell type
A549
Species or organism
Human
Tissue
Lung
Form
Liquid
Knockout validation
Sanger Sequencing
Mutation description
Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 3 and 1 bp insertion in exon 3

Alternative names

Recommended products

GBP3 KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 3 and 1 bp insertion in exon 3.

Key facts

Cell type
A549
Form
Liquid
Mutation description
Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 3 and 1 bp insertion in exon 3
Disease
Carcinoma
Concentration
Loading...

Properties

Gene name
GBP3
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing

Quality control

STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level
EU: 1 US: 1
Adherent/suspension
Adherent
Gender
Male

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
  • Do not allow the cell density to exceed 7x104 cells/cm2.
Culture medium
F-12K + 10% FBS
Cryopreservation medium
Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Storage

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Notes

Recommended control: Human wild-type A549 cell line (ab255450). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

The protein known as GBP3 also called Guanylate Binding Protein 3 is a member of the guanylate-binding protein family. This protein has a molecular mass of approximately 67 kDa. It mainly functions in cellular processes involving GTP hydrolysis which plays a significant role in certain immune responses. GBP3 expresses in various tissues including the heart placenta and lungs showing higher presence in immune-related cells and tissues.

Biological function summary

GBP3 contributes to cellular defense by promoting anti-viral states and mediating immune signaling. It has been found to associate with large protein complexes that enhance its stability and activity during inflammation. This involvement supports various immune functions and contributes to the body's response to pathogenic threats. Such actions highlight GBP3's importance in maintaining cellular immunity and promoting pathogenic resistance.

Pathways

GBP3 interacts within the interferon-gamma signaling pathway where it facilitates host defense mechanisms. The protein's activity aligns closely with the JAK-STAT pathway important for the transduction of extracellular signals from the environment to the cell nucleus. GBP3 operates alongside other proteins such as GBP1 and GBP5 which are also part of guanylate-binding proteins involved in immune regulation and protection against intracellular bacteria and viruses.

Associated diseases and disorders

Impairments in GBP3 function have connections to infectious diseases and inflammatory disorders. Studies suggest that altered GBP3 expression might relate to an increased susceptibility to viral infections such as hepatitis. Additionally abnormalities in this protein may associate with chronic inflammatory conditions like Crohn's disease. GBP3 interacts with proteins like STAT1 and GBP1 which play critical roles in modulating immune response and maintaining homeostasis within inflammatory conditions.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Sanger Sequencing - Human GBP3 knockout A549 cell line (ab267190), expandable thumbnail

    Sanger Sequencing - Human GBP3 knockout A549 cell line (ab267190)

    Allele-1: 1 bp insertion in exon3

  • Sanger Sequencing - Human GBP3 knockout A549 cell line (ab267190), expandable thumbnail

    Sanger Sequencing - Human GBP3 knockout A549 cell line (ab267190)

    Allele-2: 1 bp deletion in exon 3.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com